본문 바로가기

logo

KOR
ENG

home
ESG
Governance
주주구성

Governance

신뢰를 기반으로 가치를 만들어 갑니다.

한올바이오파마는 책임 있는 경영과 투명한 지배구조를 바탕으로 주주와의 신뢰를 쌓아가고 있습니다. 다양한 주주와의 조화로운 소통을 통해 지속가능한 성장을 추구합니다.

주주구성

발행주식

(2025.12.31)

발행주식 총수	52,240,638	100%
국내	49,205,667	94.2%
외국인	3,034,971	5.8%

주요주주

(2025.12.31)

발행주식 총수	52,240,638	100%
대웅제약	16,115,745	30.8%
국민연금	4,299,121	8.2%
자기주식	1,459,781	2.8%
기타	30,365,991	58.1%

제 53기 주주총회 안건별 찬반 내역

(2026.03.26)

안건	결의구분	회의목적사항	가결여부	의결권 있는 발행주식 총수 (1)	(1)중 의결권 행사 주식수 (A)	찬성주식수 (B)
안건	결의구분	회의목적사항	가결여부	의결권 있는 발행주식 총수 (1)	(1)중 의결권 행사 주식수 (A)	반대/기권 등 주식수 (C)
제1호의안	-	제53기(25년 01월~01일~25년12월31일) 재무제표 (이익잉여금처분계산서(안)포함) 및 연결재무제표 보고	보통 (이사회 승인)	-	-	-
제2호의안	특별	제2-1호: 정관 일부 변경의 건 - 상법 개정 관련 정관 정비	가결	50,780,857	26,087,903	21,753,511	83.4%
		제2-1호: 정관 일부 변경의 건 - 상법 개정 관련 정관 정비	가결	50,780,857	26,087,903	4,334,392	16.6%
		제2-2호: 정관 일부 변경의 건 - 기타 법령 및 표준정관에 따른 정관 정비	가결	50,780,857	26,087,903	21,753,538	83.4%
		제2-2호: 정관 일부 변경의 건 - 기타 법령 및 표준정관에 따른 정관 정비	가결	50,780,857	26,087,903	4,334,365	16.6%
제3호의안	보통	제3-1호: 이사 선임의 건 (사내이사 2명) - 사내이사 박승국	가결	50,780,857	26,087,903	25,441,264	97.5%
		제3-1호: 이사 선임의 건 (사내이사 2명) - 사내이사 박승국	가결	50,780,857	26,087,903	646,639	2.5%
		제3-2호: 이사 선임의 건 (사내이사 2명) - 사내이사 박수진	가결	50,780,857	26,087,903	25,974,558	99.6%
		제3-2호: 이사 선임의 건 (사내이사 2명) - 사내이사 박수진	가결	50,780,857	26,087,903	113,345	0.4%
제4호의안	보통	감사위원회 위원이 되는 사외이사 선임의 건 (1명) - 정인기	가결	32,328,006	7,661,312	7,618,259	99.4%
제4호의안	보통	감사위원회 위원이 되는 사외이사 선임의 건 (1명) - 정인기	가결	32,328,006	7,661,312	43,053	0.6%
제5호의안	보통	이사 보수한도 승인의 건	가결	50,780,857	26,087,903	21,436,981	82.2%
제5호의안	보통	이사 보수한도 승인의 건	가결	50,780,857	26,087,903	4,650,922	17.8%

제 52기 주주총회 안건별 찬반 내역

(2025.03.26)

안건	결의구분	회의목적사항	가결여부	의결권 있는 발행주식 총수 (1)	(1)중 의결권 행사 주식수 (A)	찬성주식수 (B)
안건	결의구분	회의목적사항	가결여부	의결권 있는 발행주식 총수 (1)	(1)중 의결권 행사 주식수 (A)	반대/기권 등 주식수 (C)
제1호의안		제52기(24년 01월~01일~24년12월31일) 재무제표 (이익잉여금처분계산서(안)포함) 및 연결재무제표 보고	보통 (이사회 승인)	-	-	-
제2호의안	보통	이사선임의 건 (기타비상무이사 1명) - 김진형 선임의 건	가결	50,765,611	29,922,234	27,463,322	98.4%
제2호의안	보통	이사선임의 건 (기타비상무이사 1명) - 김진형 선임의 건	가결	50,765,611	29,922,234	458,912	1.6%
제3호의안	보통	감사위원회 위원 선임의 건 (1명) - 김진형 선임의 건	가결	31,229,386	8,463,478	7,727,413	91.3%
제3호의안	보통	감사위원회 위원 선임의 건 (1명) - 김진형 선임의 건	가결	31,229,386	8,463,478	736,065	8.7%
제4호의안	보통	이사 보수한도 승인의 건	가결	50,765,611	27,922,234	22,469,742	80.5%
제4호의안	보통	이사 보수한도 승인의 건	가결	50,765,611	27,922,234	5,452,492	19.5%

Terms of Use

TERMS OF USE

The information provided on this site is for general informational and educational purposes only. Please read and review these Terms of Use carefully before accessing or using this Website. By accessing or using this site, you acknowledge that you have read, understood and agreed to the Terms of Use Agreement. If you do not agree to the Terms of Use, you may not access or use the site.

Use of Website

This website is designed to provide general information to the users. Some sections are specifically aimed at HanAll's employees, customers, shareholders, healthcare professionals, and the public. Your use of this website is governed by the Terms of Use Agreement, and by accessing and using this site, you agree to accept these terms without limitation or qualification.

Information

HanAll Biopharma strives to provide accurate and current information on this website, but does not guarantee the accuracy, currency, or completeness of the content. By accessing and using this website, you assume all risks associated with such use. HanAll Biopharma disclaims all express or implied warranties, including warranties of merchantability and fitness for a particular purpose. Neither HanAll Biopharma nor any parties involved in creating, producing, or delivering this website shall be liable for any damages, including direct, incidental, consequential, indirect, or punitive damages, arising from your access to, use of, or inability to use this website, or any errors or omissions in the content. This limitation of liability also includes damages to your computer equipment or any virus infections.

Reimbursement

All users to this website will agree to protect, defend, and hold harmless HanAll Biopharma and its employees, agents, suppliers, and third-party partners from all losses, expenses, damages, and costs, including reasonable attorneys' fees, aroused from your violation of these Terms of Use.

Privacy

HanAll Biopharma values the privacy of its website users. For information about your rights and responsibilities regarding the disclosure of information on this website, please refer to HanAll's Privacy Policy.

Third Party Links

The website may contain links to third-party websites that HanAll Biopharma does not control, and vice versa. These links are provided for convenience, but HanAll Biopharma cannot guarantee the accuracy or completeness of any information on third-party websites. Inclusion of any third-party link on our website does not imply endorsement or recommendation by HanAll Biopharma. Similarly, any link to our website from the other website does not imply any relationship between HanAll Biopharma and the third party. We highly encourage users to exercise caution and review the third-party's terms and policies, including their privacy policy, before using any third-party website or platform.

Forward Looking Statements

The content on this website may include forward-looking statements regarding HanAll Biopharma's financial and operational performance, business plans and prospects, and products in development, which are subject to significant risks and uncertainties. The actual results may differ materially from the expectations and projections outlined in these statements. The risks and uncertainties include, but are not limited to, the uncertainties involved in pharmaceutical research and development, regulatory decisions, competition, marketing success, patent validity, healthcare laws and regulations, and general economic conditions such as interest rates and foreign currency exchange rate fluctuations. For a more comprehensive list and description of such risks and uncertainties, please refer to HanAll Biopharma's quarterly or annual reports, which can be accessed from the press release page of this website. HanAll Biopharma is not obligated to update any forward-looking statements on this website due to new information or future events and developments.

Use of Information

Any use or misuse information or materials, except as authorized in these Terms of Use, is strictly prohibited and may violate copyright law, privacy and publicity laws, as well as communications regulations and statutes. All users are advised to comply with all applicable laws and regulations related to the use of the materials on this website.

Jurisdiction

This Terms of Use Agreement and your use of the website shall be governed by the laws of the South Korea without regard to its conflicts of laws principles.

Editorial Rights

HanAll Biopharma reserves the right to alter or delete materials from this website at any time at its discretion.

Privacy Policy

PRIVACY POLICY

Effective Date: [25 Apr. 2023]
This Privacy Policy illustrates how HanAll Biopharma ("we", “our”, “us”) use and protect information you provide through your use of this website (the "Website") or our customer inquiry and recruitment services (collectively the “Services”).

Please read this Privacy Policy carefully and feel free to contact us if you have any questions, using the contact information provided in the Contact Us section below.

Information we may collect from you

1.Customer Inquiry
When you fill out the "Form" on our Website, we may collect the following types of information:

Category	Information we may collect from you
Newsroom	Mandatory	First Name, Last Name, E-mail, Company, Department, Job title, Country

2.Recruitment
When you submit your application via “Fellowship Program” on our Website, we may collect the following types of information:

Category	Information we may collect from you
Application Form (in English)	Mandatory	Name, Date of Birth, Address, E-mail, Contact Number, Education History (Name of School, Major, Enrollment Year/Month, Graduation Year/Month, Location), Employment History (Employment Period, Company, Job Title, Job Scope, Major Task), Language, Miscellaneous (Military Status, Reason for Exemption, Veteran Status)
Application Form (in English)	Optional	Any additional information you provide including but not limited to research career, special qualifications and licenses, personal profiles on SNS.

* No sensitive information will be collected.

How we use your information

1. Recruitment
In order to proceed with recruitment process and communicate status/result of job application(s).

Sharing information with third parties
We will not disclose your information to third parties for their marketing or business purposes without your consent. However, notwithstanding the above, we may disclose your information to the following entities for recruitment purposes:

①Educational institutions in your application.
Your information (name, date of birth, major, admission year, graduation year, etc.) may be disclosed to educational institutions named in your application.

②Previous companies you worked for and reference check vendors.
Your information (i.e. name) may be disclosed to your previous workplaces and reference check vendors.

③Service providers.
We may disclose your information to companies that provide Services on our behalf. These entities cannot use your information for purposes other than providing Services on our behalf.

④Other parties when required by law or as necessary to protect our rights.
There may be instances where we disclose your information to other parties:
- to comply with legal obligations or legally binding disclosure orders (such as a search warrant or other court/regulatory order);
- to verify or ensure compliance with the terms and policies governing our Services; and
- to protect the rights, property, or safety of us or any of our business partners or customers.

⑤Other parties in connection with corporate transactions.
We may disclose your information to a third party as part of a merger or transfer, or in the event of a bankruptcy.

⑥Other parties with your consent or at your direction.
In addition to the disclosures described in this Privacy Policy, we may disclose information about you to third parties when you consent to or request such disclosure.

Your Rights

To the extent permitted under applicable law(s), you may ask us to return, destroy, or correct any inaccuracies regarding your personal information. You may also ask us to restrict or limit our use of your personal information unless such restriction or limitation prevents us from complying with applicable law(s) or meeting a legal obligation.

However, your rights above may be limited in cases where your request would disclose personal information of a third party or where such a request would infringe the rights of a third party (including our rights) or if you ask us to delete information which we are required by law to preserve or have legitimate interests in retaining. Other relevant exemptions may exist under the GDPR and national laws. We will inform you of the relevant exemptions when responding to your request. To make such a request concerning your rights set forth herein, please refer to the Contact Us section.

International Transfer of Information

We are a company based in Korea, and your use of our Website and Services will involve the transfer, storage, and processing of your personal information in Korea. Please note that the information protection laws and other applicable laws of countries outside the European Economic Area (“EEA”), to which your information may be transferred, might not be as comprehensive as those in your country. We will take appropriate measures, in compliance with applicable law, to ensure that your personal information remains protected.

Data Retention

We will retain your personal information for a reasonable period of time that enables us to communicate with you, to provide you with Services, to maintain business records for audit purposes, to meet recordkeeping requirements under applicable law(s), to defend or bring any legal claims and to deal with any queries or complaints you may have.

Keeping Your Information Secure

We have put in place reasonable measures to safeguard the information we collect in connection with the Services. However, please note that although reasonable steps will be taken to protect your information, no website, internet transmission, computer system or wireless connection is 100% secure from any and all potential threats.

For US Residents Only

CHILDREN’S PRIVACY
The Site is not directed to individuals under the age of thirteen (13), and we do not knowingly collect personal data from children under the age of 13.

In connection with the Services, we will not knowingly solicit or collect personal information from children under the age of 13. In the event we do collect such personal information inadvertently or unknowingly and we later learn about it, we will promptly delete such information. If you believe that children under the age of 13 may have provided personal information to us, please contact us using the Contact Us section of this Privacy Policy.

Changes to this Privacy Policy

From time to time, we may update this Privacy Policy. Any changes will be effective when we post the revised Privacy Policy. This Privacy Policy was last updated as of the effective date listed above. If the Privacy Policy changes in a way that significantly affects how we handle personal data, we will not use the personal data we previously gathered in the manner described in the new policy without providing notice and/or obtaining your consent, as appropriate. Minor changes to the policy may occur that will not significantly affect our use of personal data without notice or consent. We encourage you to periodically review this page for the latest information on our privacy practices.